Population-Based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009

被引:15
作者
Shin, Sang-Hoon [1 ]
Jung, Kyu-Won [2 ]
Ha, Johyun [2 ]
Lee, Seung Hoon [1 ]
Won, Young-Joo [2 ]
Yoo, Heon [1 ]
机构
[1] Natl Canc Ctr, Neurooncol Clin, Goyang 10408, South Korea
[2] Natl Canc Ctr, Korea Cent Canc Registry, Goyang 10408, South Korea
来源
CANCER RESEARCH AND TREATMENT | 2015年 / 47卷 / 04期
关键词
Central nervous system; Lymphoma; Neoplasms; Registries; Incidence; Survival; Korea; CONTINUING INCREASE; AIDS;
D O I
10.4143/crt.2014.085
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Primary central nervous system lymphoma (PCNSL) is an uncommon brain tumor accounting for 2%-5% of all primary brain tumors. Few population-based analyses of survival for patients with PCNSL have been conducted, particularly in Asian countries. Materials and Methods Using the Korea National Cancer Incidence Database, 1,062 cases of PCNSL newly diagnosed from 1999 to 2009 were analyzed. The crude rate, age-standardized rate (ASR), and annual percent change were calculated. To estimate the observed survival, we restricted the data to between 1999 and 2007 and followed the cases until December 2010. The overall survival was estimated using the Kaplan-Meier method, and piecewise Poisson regression model. Results The ASR for PCNSL between 1999 and 2009 was 0.17 per 100,000, and the annual percent change from 1999 to 2009 was 8.8% (p < 0.001). The ASR of males was higher than that of females, and the older groups (60s or over) showed the largest increase in incidence rates. For all ages, the five-year survival from PCNSL was 29.9% between 1999 and 2007. Survival from PCNSL is known to show strong association with age at diagnosis. Conclusion These results are similar to those of previous studies. Our findings may be helpful to clinicians and patients in determining long-term prognoses for PCNSL.
引用
收藏
页码:569 / 574
页数:6
相关论文
共 19 条
[1]  
[Anonymous], 2010, CANCER
[2]  
[Anonymous], 1960, CANC MORTALITY SELEC
[3]  
Curado M.P., 2007, Cancer Incidence in Five Countries, V9, P160
[4]  
EBY NL, 1988, CANCER-AM CANCER SOC, V62, P2461, DOI 10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO
[5]  
2-M
[6]   Prognostic scoring system for primary CNS lymphomas: The international extranodal lymphoma study group experience [J].
Ferreri, AJM ;
Blay, JY ;
Reni, M ;
Pasini, F ;
Spina, M ;
Ambrosetti, A ;
Calderoni, A ;
Rossi, A ;
Vavassori, V ;
Conconi, A ;
Devizzi, L ;
Berger, F ;
Ponzoni, M ;
Borisch, B ;
Tinguely, M ;
Cerati, M ;
Milani, M ;
Orvieto, E ;
Sanchez, J ;
Chevreau, C ;
Dell'Oro, S ;
Zucca, E ;
Cavalli, F .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :266-272
[7]  
Forman D., 2014, Cancer incidence in five continents
[8]  
FREEMAN C, 1972, CANCER, V29, P252, DOI 10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO
[9]  
2-#
[10]   PRIMARY CENTRAL NERVOUS-SYSTEM LYMPHOMA [J].
HOCHBERG, FH ;
MILLER, DC .
JOURNAL OF NEUROSURGERY, 1988, 68 (06) :835-853